Skripsi
POLA KEPEKAAN BAKTERI Staphillococcus Aureus TERHADAP ANTIBIOTIK Vancomycin DI RUMAH SAKIT MOHAMMAD HOESIN PALEMBANG PERIODE OKTOBER 2012-SEPTEMBER 2013
Introduction: Staphylococcus aureus is the most common bacteria that causes infections in the world. Methicillin-resistant Staphylococcus aureus (MRSA) is a Staphylococcus aureus strain that resistant to p-lactam and non-P-lactam antibiotics. Currently, glycopeptide vancomycin is the drug of choice for the treatment of MRSA infections. Increase use and improper administration of vancomycin for MRSA treatment may increased resistance of Staphylococcus aureus to vancomycin. Therefore, the purpose of this study vvas to determine the suspectibility pattern of Staphylococcus aureus to vancomycin in RSMH Palembang. Method: This study was a descriptive observational study using cross-sectional approach. The research data was derived from secondary data of suscpectibility test results obtained from the Clinical Microbiology Laboratory of RSMH Palembang from October 2012-September 2013. Results: The total number of isolates that contain Staphylococcus aureus from various clinical specimens are 1118 isolates. Specimens with the most S.aureus isolates are from sputum (327 isolates). Suspectibility test data showed 19 isolates with inhibition zone diameter >12mm, 1 isolates with inhibition zone diameter 10-1 lmm and 1098 isolates with inhibition zone diameter >12mm. Conclusion: From 1118 S.aureus isolates, 19 isolates (1.7%) is Vancomycin Resistant Staphylococcus aureus (VRSA), 1 isolate (0.1%) is Vancomycin Intermediate Staphylococcus aureus (VISA) and 1098 isolates (98.2%) is Vancomycin Semilive Staphylococcus aureus (17SSA).
Inventory Code | Barcode | Call Number | Location | Status |
---|---|---|---|---|
1407000406 | T80266 | T802662014 | Central Library (Referens) | Available but not for loan - Not for Loan |
No other version available